Physician profile
Benjamin Teitelbaum
NPI 1457364333
$9,028.41
in general payments reported to CMS, 2019-2025
13 companies · $773 in 2025
The $773 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $693 · 2021: $2,669 · 2022: $2,004 · 2023: $1,029 · 2024: $1,106 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,908.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,244.85 | 2020-2025 | Inspire |
| Intersect Ent, INC. | $2,010.82 | 2019-2021 | |
| Stryker Corporation | $1,555.24 | 2019-2025 | Xpress Loprofile |
| Medical Device Business Services, INC. | $528.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $471.62 | 2019-2025 | Dupixent |
| Acclarent, INC | $452.24 | 2019-2022 | |
| Medtronic, INC. | $192.70 | 2022-2025 | Propel |
| Aerin Medical INC. | $177.04 | 2022-2025 | |
| Genzyme Corporation | $144.43 | 2019-2021 | |
| Lilly USA, LLC | $120.00 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $91.64 | 2025 | Nucala |
| Amgen INC. | $21.96 | 2025 | |
| Smith+Nephew, INC. | $17.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Teitelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.